Biotransformation of iomeglamic acid (Falignost)
Pfeifer, S.; Schäffner, J.; Bornschein, I.
Die Pharmazie 27(9): 616-617
1972
ISSN/ISBN: 0031-7144 PMID: 5086367 Document Number: 49279
Document emailed within 1 workday
Related Documents
Fahr, F.; Kala, H.; Fries, G.; Helbig, G. 1988: Improvement of the solubility of problem drugs. 18. Iomeglamic acid-PVA effervescent powder Die Pharmazie 43(3): 217Fahr, F.; Kala, H.; Hückel, T.; Fries, G. 1988: Improvement of the solubility of problem drugs. 17. Processing of iomeglamic acid/methylcellulose coprecipitates in tablets Die Pharmazie 43(3): 216
Schwartz, M.A.; Kolis, S.J.; Williams, T.H.; Gabriel, T.F.; Toome, V. 1973: Biotransformation of 2-hydroxynicotinic acid: N-riboside formation in vivo Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(3): 557-564
Shumkova, E.S.; Solianikova, I.P.; Plotnikova, E.G.; Golovleva, L.A. 2009: Biotransformation of p-toluic acid by bacterium Rhodococcus ruber P25 Mikrobiologiia 78(3): 421-423
Gurinovich, V.A.; Moĭseenok, A.G. 1986: Proteinization and biotransformation of pantothenic acid in the liver during the activation of lipogenesis Voprosy Pitaniia 6: 50-54
Poupon, R.Y.; Raizman, A.; Brumault, J.C.; Infante, R.; Darnis, F. 1979: Hepatic biotransformation and conjugation of dehydrocholic acid in patients with cirrhosis Gastroenterologie Clinique et Biologique 3(12): 879-884
Populaire, P.; Terlain, B.; Pascal, S.; Decouvelaere, B.; Renard, A.; Thomas, J.P. 1973: Biological behavior: serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men Annales Pharmaceutiques Francaises 31(12): 735-749
Reziapkin, V.I.; Gurinovich, V.A.; Chiger, V.B.; Moiseenok, A.G. 1989: Distribution and biotransformation of labelled pantothenate in cytoplasmic and mitochondrial fractions of the rat liver with a deficiency of pantothenic acid Voprosy Pitaniia 5: 50-53
Loknitskaia, N.N.; Rotenberg, I.S.; Fonshteĭn, L.M.; Shuliakovskaia, T.S. 1986: Study of promutagen biotransformation in the Ames test. III. the role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide Genetika 22(9): 2259-2264
Walter-Sack, I.; de Vries, J.X.; von Bubnoff, A.; Pfleilschifter, V.; Raedsch, R. 1995: Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites? European Journal of Medical Research 1(1): 16-20
Baumann, L.S.; Oresajo, C.; Yatskayer, M.; Dahl, A.; Figueras, K. 2013: Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): 266-269
Rücker, G.; Neugebauer, M.; Heiden, P.G. 1988: The biotransformation of fenetylline Arzneimittel-Forschung 38(4): 497-501
Gillette, J.R.; Hinson, J.A. 1978: Biotransformation of drugs Advances in Experimental Medicine and Biology 97: 5-25
Kharasch, E.D. 1995: Biotransformation of sevoflurane Anesthesia and Analgesia 81(6 Suppl): S27-S38
Taylor, J.A. 1974: Pharmacokinetics and biotransformation of chlorpropamide in the rat and dog Drug Metabolism and Disposition: the Biological Fate of Chemicals 2(3): 221-227
Bornschein, I.; Wierer, A.; Borchert, H.H.; Pfeifer, S. 1976: Biotransformation of trapidil (Rocornal) Die Pharmazie 31(1): 51
Borchert, H.H.; Bornschein, I.; Pfeifer, S.; Kraft, R. 1977: Biotransformation of 9,9-dioxopromethazine (Prothanon) Die Pharmazie 32(8-9): 489-496
Lintz, W.; Erlaçin, S.; Frankus, E.; Uragg, H. 1981: Biotransformation of tramadol in man and animal Arzneimittel-Forschung 31(11): 1932-1943
Godawska-Matysik, A.; Pekala, E.; Kieć-Kononowicz, K. 2004: The research on biotransformation of praziquantel Acta Poloniae Pharmaceutica 61 Suppl: 75-78
Bornschein, I.; Pfeifer, S. 1979: Biotransformation of promethazine (Prothazin) Die Pharmazie 34(11): 750